Amgen Submits Supplemental Biologics License Application For Nplate® (romiplostim)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/20/2026

1. TGT
2. EL
3. SPY
4. BILL
5. MRK
6. MRNA
7. ADI
8. LOW
9. WMT
10. TJX

Go back to Amgen Submits Supplemental Biologics License Application For Nplate® (romiplostim)
Amgen Inc (NASDAQ: AMGN) Delayed: 432.46 -9.9 (2.24%)
Previous Close $442.36    52 Week High $176.85 
Open $435.78    52 Week Low $133.64 
Day High $441.34    P/E 65.13 
Day Low $431.46    EPS $6.64 
Volume 1,341,286